We are live on
!
Find out more
UBV
United Bank (Virginia) Portfolio holdings
AUM
$853M
1-Year Est. Return
34.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.46%
1 Year Est. Return
+34.07%
3 Year Est. Return
+76.1%
5 Year Est. Return
+99.67%
10 Year Est. Return
+313.94%
AUM
$786M
AUM Growth
-$52.9M
(-6.3%)
Cap. Flow
-$20.8M
Cap. Flow
% of AUM
-2.65%
Top 10 Holdings %
Top 10 Hldgs %
45.09%
Holding
144
New
10
Increased
24
Reduced
57
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$8.69M |
| 2 |
PepsiCo
PEP
|
+$8.66M |
| 3 |
Aflac
AFL
|
+$8.52M |
| 4 |
Illinois Tool Works
ITW
|
+$8.44M |
| 5 |
Lockheed Martin
LMT
|
+$8.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quest Diagnostics
DGX
|
+$13.9M |
| 2 |
US Bancorp
USB
|
+$13.6M |
| 3 |
Pfizer
PFE
|
+$10.8M |
| 4 |
United Parcel Service
UPS
|
+$9.4M |
| 5 |
Target
TGT
|
+$8.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.73% |
| 2 | Technology | 14.16% |
| 3 | Financials | 11.22% |
| 4 | Healthcare | 7.72% |
| 5 | Consumer Staples | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
UnitedHealth
UNH
$365B
| $257K | 0.03% |
490
-16
| -3% | -$8.18K |
|
127
iShares Biotechnology ETF
IBB
$9.86B
| $244K | 0.03% |
1,908
| – | – |
|
128
Palo Alto Networks
PANW
$316B
| $244K | 0.03% |
1,430
-966
| -40% | -$179K |
|
129
Norfolk Southern
NSC
$75.5B
| $235K | 0.03% |
994
| – | – |
|
130
Colgate-Palmolive
CL
$73.8B
| $225K | 0.03% |
2,400
| – | – |
|
131
Zimmer Biomet
ZBH
$18.5B
| $208K | 0.03% |
+1,838
| New | +$197K |
|
132
Cincinnati Financial
CINF
$26.5B
| $207K | 0.03% |
1,403
| – | – |
|
133
Trevi Therapeutics
TRVI
$2.52B
| $196K | 0.03% |
31,200
| – | – |
|
134
Cardiff Oncology
CRDF
$78.6M
| $71.9K | 0.01% |
22,911
| – | – |
|
|
ATYR
135
aTyr Pharma
ATYR
$53M
| $41.8K | 0.01% |
+13,830
| New | +$50.4K |
|
136
Vor Biopharma
VOR
$1.22B
| $11K | ﹤0.01% |
765
| – | – |
|
137
Accenture
ACN
$110B
| – | – |
-588
| Closed | -$207K |
|
138
ASML
ASML
$697B
| – | – |
-302
| Closed | -$209K |
|
|
AUTL
139
Autolus Therapeutics
AUTL
$559M
| – | – |
-10,850
| Closed | -$25.5K |
|
140
Dow Inc
DOW
$22B
| – | – |
-5,240
| Closed | -$210K |
|
141
Intuit
INTU
$91.3B
| – | – |
-330
| Closed | -$207K |
|
142
iShares Russell 1000 ETF
IWB
$50.2B
| – | – |
-650
| Closed | -$209K |
|
143
Lineage Cell Therapeutics
LCTX
$278M
| – | – |
-12,000
| Closed | -$6.03K |
|
144
Talphera
TLPH
$72.1M
| – | – |
-14,800
| Closed | -$7.76K |
|
Similar funds
EPIMS
PCM
BOTOTLSJU
QIM
NOCM
OAM
BCM
VAS
United Bank (Virginia)'s Q1 2025 Portfolio in Review
As of Q1 2025, United Bank (Virginia) held 144 positions worth $786M, down 6.3% from $839M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
United Bank (Virginia)'s Q1 2025 filing shows 10 new, 24 increased, 57 reduced and 8 closed positions. Its largest new stake was Lockheed Martin: 18,252 shares worth $8.15M. The largest sale was Quest Diagnostics, an estimated $13.9M.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 24% a quarter earlier, followed by Technology and Financials.
- United Bank (Virginia)'s largest Q1 2025 buy was Lockheed Martin: 18,252 shares worth $8.15M.
- United Bank (Virginia) added most to Honeywell in Q1 2025, an estimated $8.69M increase.
- United Bank (Virginia)'s biggest Q1 2025 reduction was Quest Diagnostics, cutting an estimated $13.9M.
- United Bank (Virginia) fully exited Dow Inc in Q1 2025, selling an estimated $210K.
- United Bank (Virginia)'s ten largest holdings make up 45% of its $786M portfolio in Q1 2025.
- United Bank (Virginia) opened 10 new positions and closed 8 in Q1 2025.
- United Bank (Virginia)'s portfolio value fell 6.3% quarter-over-quarter to $786M.
Based on United Bank (Virginia)'s 13F filing for Q1 2025, filed 14 May 2025.